Evaluating Sarconesiopsis magellanica blowfly-derived larval therapy and comparing it to Lucilia sericata-derived therapy in an animal model

Larval therapy is used as alternative treatment for hard-to-heal chronic and infected wounds. Lucilia sericata is the most used blowfly species. However, it has been shown recently that Sarconesiopsis magellanica larval excretions and secretions have potent antibacterial activity; this blowfly belon...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2016
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23641
Acceso en línea:
https://doi.org/10.1016/j.actatropica.2015.10.024
https://repository.urosario.edu.co/handle/10336/23641
Palabra clave:
Antibiotics
Bacterial disease
Diabetes
Fly
Lagomorph
Medicine
Modeling
Animal experiment
Animal model
Animal tissue
Antibacterial activity
Antibiotic therapy
Article
Bacterial load
Calliphoridae
Chronic wound
Colony forming unit
Comparative effectiveness
Controlled study
Debridement
Diabetes mellitus
Intermethod comparison
Lucilia sericata
Maggot therapy
Nonhuman
Oryctolagus cuniculus
Pseudomonas infection
Sarconesiopsis magellanica
Staphylococcus infection
Wound healing
Wound healing impairment
Wound infection
Animal
Comparative study
Diptera
Disease model
Larva
Pathology
Rabbit
Wound infection
Animalia
Bacteria (microorganisms)
Calliphoridae
Lucilia sericata
Oryctolagus cuniculus
Pseudomonas aeruginosa
Staphylococcus
Alloxan
Antiinfective agent
Alloxan
Animals
Anti-bacterial agents
Diptera
Larva
Rabbits
Wound healing
Wound infection
Bacterial infection
Diabetes
Larval therapy
Lucilia sericata
Sarconesiopsis magellanica
Wound healing
experimental
animal
experimental
Diabetes mellitus
Diabetes mellitus
Disease models
Rights
License
Abierto (Texto Completo)
Description
Summary:Larval therapy is used as alternative treatment for hard-to-heal chronic and infected wounds. Lucilia sericata is the most used blowfly species. However, it has been shown recently that Sarconesiopsis magellanica larval excretions and secretions have potent antibacterial activity; this blowfly belongs to the Calliphoridae family.The present work has dealt with evaluating larval therapy using S. magellanica on wounds induced in diabetic rabbits and its action was compared to the effect induced by L. sericata. Twelve New Zealand White rabbits (. Oryctolagus cuniculus) were used; they were divided into 4 groups, the first two being treated with larval therapy derived from both aforementioned necrophagous blowflies, an antibiotic was used in the third and the fourth was used as control. All the animals were wounded on the back and infected with Pseudomonas aeruginosa and Staphylococcus aureus.Samples of the secretion from each animal's infected wound were taken and sown on blood agar. The colony forming units were then counted. The PUSH scale was used for the macroscopic evaluation of the wounds.Bacterial control was encountered 48. h post-treatment in the treatments involving larval therapy and to a lesser extent with the antibiotic. Likewise, wound debridement was quicker and more efficient with larval therapy compared to the antibiotic group; however, wound closing time was 23 days in all treatments. The group treated with S. magellanica larvae had relatively quicker evolution until the proliferation phase and the start of maturation, even though there were no significant differences between both blowfly species evaluated here regarding treatments by the end of the treatment period.The present study has validated the diabetic rabbit model for inducing chronic wounds regarding larval therapy and has likewise confirmed the effectiveness of S. magellanica-derived larval therapy as an alternative for curing and healing wounds. © 2015 Elsevier B.V.